Zelenirstat

N/A

Report date: 2025/03/26 11:40:46
NMEFirst In Class

Base Information

Drug NameZelenirstat
Drug Alias NameDDD-86481DDD86481PCLX-001PCLX-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeptide N-myristoyltransferase 1 inhibitorsPeptide N-myristoyltransferase 2 inhibitors
TargetsPeptide N-myristoyltransferase 1Peptide N-myristoyltransferase 2
Therapy Area/IndicationsSolid tumoursColorectal NeoplasmsGlioblastoma +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Dundee
China Registration ClassN/A

Develop Information

Active CompaniesPacylex Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursColorectal NeoplasmsGlioblastoma +[6] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank